Nchi: Uingereza
Lugha: Kiingereza
Chanzo: VMD (Veterinary Medicines Directorate)
Ivermectin, Triclabendazole
EU Pharmaceuticals Ltd
QP54AA51
Ivermectin, Triclabendazole
Oral suspension
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Sheep
Endectocide
Authorized
2021-11-16
Issued: November 2021 AN: 00517/2020 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tribamec Duo 50 mg/ml & 1 mg/ml Oral Suspension for Sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE INGREDIENTS: Triclabendazole 50 mg/ml Ivermectin 1 mg/ml EXCIPIENTS: Methyl parahydroxybenzoate (E218) 1.2 mg/ml Propyl parahydroxybenzoate 0.5 mg/ml Benzyl alcohol 27.0 mg/ml For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension Cream coloured aqueous oral suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES For sheep over 3 months of age. 4.2 INDICATION FOR USE Treatment of mixed trematode (fluke) and nematode or arthropod infections due to gastrointestinal roundworms, lungworms, liver fluke and nasal bots. GASTROINTESTINAL NEMATODES (ADULT AND IMMATURE): _Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta, Trichostrongylus _ _spp, Cooperia spp, Nematodirus spp_ including _ N. battus_, _ Strongyloides papillosus, _ _Oesophagostomum spp_, and adult _Chabertia ovina._ Inhibited larval stages and benzimidazole resistant strains of _Haemonchus contortus_ and _Teladorsagia (Ostertagia) circumcincta_ are also controlled. LIVER FLUKE (MATURE, IMMATURE AND EARLY IMMATURE STAGES DOWN TO LESS THAN 1 WEEK OF AGE): _Fasciola hepatica_ Issued: November 2021 AN: 00517/2020 Page 2 of 6 LUNGWORMS (ADULT AND IMMATURE): _Dictyocaulus filaria_ NASAL BOTS (ALL STAGES): _Oestrus ovis_ 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients or any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: • Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. • Underdosing which may be due to underestimation of bodyweight, misadministration of the product or lack of calibration of the dosing de Soma hati kamili